Boston Scientific Corporation BSX has received regulatory approval to
market the RELIANCE® 4-FRONT™ lead, its next generation implantable
defibrillation lead now available in Europe and Asia. Defibrillation leads
are insulated wires that connect an implantable cardioverter defibrillator
(ICD) or cardiac resynchronization therapy defibrillator to the heart for
treatment of heart failure and sudden cardiac arrest.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in